SCHEMBL2760411

SCHEMBL2760411

Cc1cc(-c2cccnc2)cc2nc(N)sc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 2/20 0.57
PIK3CA P42336 2/20 0.57
PI4KA P42356 2/20 0.57
PI4KB Q9UBF8 2/20 0.57
PIP5K1C O60331 1/20 0.57
SMN1; SMN2 Q16637 2/20 0.53
MKNK1 Q9BUB5 2/20 0.44
MKNK2 Q9HBH9 2/20 0.44
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 1/20 0.43
PSIP1 O75475 1/20 0.43
AXL P30530 1/20 0.43
CYP2A6 P11509 5/20 0.42
CYP3A4 P08684 4/20 0.42
CYP2E1 P05181 3/20 0.42
CYP2D6 P10635 3/20 0.42
CYP2C9 P11712 3/20 0.42
CYP2B6 P20813 3/20 0.42
CYP2C19 P33261 3/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12264114 0.80 PIK3CD (0.53) PIK3CDPIK3CAPI4KAPI4KBPIP5K1C
SCHEMBL12509852 0.80 PIK3CA (0.56) PIK3CDPIK3CAPI4KAPI4KBPIP5K1C
SCHEMBL222987 0.78 PIK3CD (0.51) PIK3CDPIK3CAPI4KAPI4KBPIP5K1C
SCHEMBL222082 0.78 CFTR (0.48) PIK3CDPIK3CAPI4KAPI4KBPIP5K1C
SCHEMBL222311 0.77 PIK3CD (0.50) PIK3CDPIK3CAPI4KAPI4KBPIP5K1C
SCHEMBL14347505 0.73 ABL1 (0.53)
SCHEMBL3710444 0.72 PIK3CA (1.00) PIK3CDPIK3CAPI4KAPI4KBPIP5K1C
SCHEMBL189244 0.72 ASH1L (0.59) PIK3CDPIK3CAPI4KAPI4KBPIP5K1C
SCHEMBL13036623 0.71 CYP2A6 (0.62) SMN1; SMN2MKNK1MKNK2KDM4EMEN1
SCHEMBL13812998 0.71 CYP2A6 (0.52) SMN1; SMN2MKNK1MKNK2MEN1PSIP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004221-A1 Antibacterial Compositions BIOTA EUROPE LIMITED (GB) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004221-A1 Antibacterial Compositions CYCS, COX6C, RPS6 PIK3CD 3480/4885PIK3CA 4048/4885PI4KA 3713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.